Melatonin in humans - where we are 40 years after its discovery

Neuroendocrinology Letters

Volumn 20, Issue 3-4, 1999, Pages 179-188

  Karasek, Michal ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Melatonin; Pineal gland

Indexed keywords

FREE RADICAL; HYPOPHYSIS HORMONE; MELATONIN; SCAVENGER;

AMENORRHEA; ANOREXIA NERVOSA; CANCER; CIRCADIAN RHYTHM; CONFERENCE PAPER; ENDOCRINE DISEASE; HEART DISEASE; HORMONE METABOLISM; HORMONE SYNTHESIS; HUMAN; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; JET LAG; MALE INFERTILITY; MELANOPHORE; MENTAL DISEASE; NEUROLOGIC DISEASE; PINEAL GLAND FUNCTION; PRECOCIOUS PUBERTY; SENESCENCE; SLEEP DISORDER;

EID: 0032711550     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (96)

1. Kappers J Ariëns. Short history of pineal discovery and research. Progr Brain Res 1979; 52:3-22.
2. Zrenner C. Theories of pineal function from classical antiquity to 1900: A history. Pineal Res Rev 1985; 3:1-40.
3. Kitay J, Altschule MD. The pineal gland. Cambridge: Harvard Univ Press; 1954.
4. Lerner AB, Case JD, Takahashi Y, Lee TH, Mori N. Isolation of melatonin, pineal factor that lightens melatonytes. J Am Chem Soc 1958; 80:2587.
5. Reiter RJ, Chen L-D, Poeggeler BH, Barlow-Walden L, Sewerynek E, Melchiori D. Antioxidant actions of melatonin and related compounds. In: Cadenas E, Packer L, editors. Handbook of antioxidants. New York: Marcel Dekker; 1996. p. 513-41.
6. Harderland R, Balzer I, Fuhrberg B, Behrmann G. Melatonin in unicellular organisms and plants. Front Horm Res 1996; 21:1-6.
7. Ebadi M. Regulation of the synthesis of melatonin and its significance to neuroendocrinology. In: Reiter RJ, editor. The pineal gland. New York: Raven Press; 1984. p. 1-37.
8. Arendt A. Melatonin and the mammalian pineal gland. London: Chapman & Hall; 1995.
9. Pöggeler B, Balzer I, Hardeland R, Lerchl A. Pineal hormone melatonin oscillates also in the dinoflagellate Gonyaulax polyedra. Naturwissenschaften 1991; 78:268-9.
10. Kennaway DJ, Stamp GE, Goble FC. Development of melatonin production in infants and the impact of prematurity. J Clin Endocrinol Metab 1992; 75:367-9.
11. Reiter RJ. Neuroendocrine effects of the pineal gland and of melatonin. In: Ganong WF, Martini L, editors. Frontiers in Neuroendocrinology, vol. 7. New York: Plenum; 1982. p. 287-316.
12. Sugden D. Melatonin biosynthesis in the mammalian pineal gland. Experientia 1989; 45:922-31.
13. Reiter RJ. Pineal melatonin production: Photoperiodic and hormonal influences. Adv Pineal Res 1986; 1:77-87.
14. Webb SM, Champney TH, Lewinski AK, Reiter RJ. Photoreceptor damage and eye pigmentation: Influence on the sensitivity of rat pineal N-acetyltransferase activity and melatonin levels to light at night. Neuroendocrinology 1985; 40:205-9.
15. Reiter RJ, Hurlbut EC, Brainard GC, Steinlechner S, Richardson BA. Influence of light irradiance on hyroxyindole-O-methyltransferase activity, serotonin N-acetyltransferase activity, and radioimmunoassayable melatonin levels in the pineal gland of the diurnally active Richardson's ground squirrel. Brain Res 1983; 288:151-7.
16. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Markley SP. Light suppresses melatonin secretion in humans. Science 1980; 210:1267-9.
17. Brainard GC, Gaddy JR, Ruberg FL, Barker FM, Hanifin JP, Rollag MD. Ocular mechanisms that regulate the human pineal gland. Adv Pineal Res 1994; 8:415-32.
18. Reiter RJ. Oxygen radical detoxification processes during aging: The functional importance of melatonin. Aging Clin Exp Res 1995; 7:430-51.
19. Bergiannaki JD, Soldatos CR, Paparrigopoulos TJ, Syrengelas M, Stefanis CN. Low and high melatonin excretors among healthy individuals. J Pineal Res 1995; 18:159-64.
20. Lang U. Melatonin and puberty. Pireal Res Rev 1986; 4:199-243.
21. Gupta D, Attanasio A. Pathophysiology of pineal function in health and disease in children. Pineal Res Rev 1988; 6:261-300.
22. Gupta D. Human development and the pineal gland. In: Gupta D, Reiter RJ, editors. The pineal gland during development: from fetus to adult. London: Croom Helm; 1986. p. 117-133.
23. Waldhauser F, Boepple PA, Cowley WF, Jr. Low nocturnal serum melatonin levels in precocious puberty. Adv Pineal Res 1991; 5:329-31.
24. Puig-Domingo M, Webb SM, Serrano J, Peinaro MA, Corcoy R, Ruscalleda J, et al. Melatonin-related hypogonadotropic hypogonadism. N Engl J Med 1992; 327:1356-9.
25. Karasek M, Pawlikowski M, Nowakowska-Jankiewicz B, Kolodziej-Maciejewska H, Zieleniewski J, Cieslak D, et al. Circadian variations in plasma melatonin, FSH, LH, prolactin and testosterone levels in infertile men. J Pineal Res 1990; 9:149-57.
26. Berga SL, Mortola JF, Yen SSC. Amplification of nocturnal melatonin secretion in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 1988; 66:242-4.
27. Laughlin GA, Loucks AB, Yen SSC. Marked augmentation of nocturnal melatonin secretion in amenorreic athletes, but not in cycling atletes: Unaltered by opioidergic or dopaminergic blockade. J Clin Endocrinol Metab 1991; 73:1321-6.
28. Arendt J, Bhanji S, Franey C, Mattingly D. Plasma melatonin levels in anorexia nervosa. Br J Psychitr 1992; 161:361-4.
29. Rao ML, Mager T. Influence of the pineal gland on pituitary function in humans. Psychoneuroendocrinology 1987; 12: 141-7.
30. Webley GE, Böhle A, Leidenberger F. Positive relationship between nocturnal concentrations of melatonin and prolactin, and a stimulation of prolactin after melatonin administration in young men. J Pineal Res 1988; 5:19-23.
31. Webley GE, Lenton EA. The temporal relationship between melatonin and prolactin in women. Fertil Steril 1987; 48: 218-22.
32. Waldahauser F, Lieberman HR, Lunch HJ, Waldhauser M, Herkner K, Frish H, et al. A pharmacological dose of melatonin increases PRL levels in males without altering those of GH, LH, FSH, TSH, testosterone or cortisol. Neuroendocrinology 1987; 46:125-30.
33. Valcavi R, Dieguez C, Azzarito C, Edwards CA, Dotti C, Page MD, et al. Effect of oral administration of melatonin on GH responses to GRF 1-44 in normal subjects. Clin Endocrinol 1987; 26:453-8.
34. Lissoni P, Resentini M, Mauri R, De Medici C, Morabito F, Esposti D, et al. Effect of acute injection of melatonin on the basal secretion of hypophyseal hormones in prepubertal and pubertal healthy subjects. Acta Endocrinol 1986; 111:305-11.
35. Vaughan GM. Melatonin in humans. Pineal Res Rev 1984; 2: 141-201.
36. Werner S, Brismar K, Wetterberg L, Eneroth P. Circadian rhythms of melatonin, prolactin, growth hormone and cortisol in patients with pituitary adenomas, empty cell syndrome and Cushing syndrome due to adrenal tumours. Adv Biosc 1981; 29:357-63.
37. Soszynski P, Slowinska-Srednicka J, Kasperlik-Zaluska A, Zgliczynski S. Decreased melatonin concentration in Cushing's syndrome. Horm Metab Res 1989; 21:673-4.
38. Lewinski A. Some aspects of the pineal-thyroid interrelationship and their possible involvement in the regulation of function and growth of these two glands. Adv Pineal Res 1990; 4: 175-88.
39. Soszynski P, Zgliczynski S, Pucilowska J. The circadian rhythm of melatonin in hypothyroidism and hyperthyroidism. Acta Endocrinol (Copenh) 1988; 119:240-4.
40. Maestroni GJM. The immunoneuroendocrine role of melatonin. J Pineal Res 1993; 14:1-10.
41. Morrey KM, McLachlan JA, Bakouche O. Activation on human monocytes by the pineal hormone melatonin. J Immunol 1994; 153:2671-80.
42. Neri B, Brocchi A, Cagnoni M. Effects of melatonin administration on cytokine production in patients with advanced solid tumors. Oncology Reports 1995; 2:45-7.
43. Guerrero JM, Rafii-El-Ildrissi M, Garcia-Rerganeda A, Garcia-Maurino S, Gilhaba M, Pozo D, et al. Mechanisms of action of melatonin on the human immune system. Membrane versus nuclear receptors. Front Horm Res 1997; 23:43-51.
44. Karasek M. Relationship between the pineal gland and experimentally induced malignant tumors. Front Horm Res 1997; 23:99-106.
45. Tamarkin L, Danforth D, Lichter A, De Moss E, Cohen M, Chabner B, et al. Decreased nocturnal plasma melatonin peak in patients with estrogen positive breast cancer. Science 1982; 216:1003-5.
46. Bartsch C, Bartsch H, Fuchs U, Lippert TH, Bellmann O, Gupta D. Stage-dependent depression of melatonin in patients with primary breast cancer. Cancer 1989; 64:426-33.
47. Bartsch C, Bartsch H, Gluchter SM, Harzmann R, Attanasio A, Bichler KH, et al. Circadian rhythms in serum melatonin, prolactin and growth hormone in patients with benign and malignant tumours of the prostate and non-tumour controls. Neuroendocrinol Lett 1983; 5:377-86.
48. Khoory R, Stemme D. Plasma melatonin levels in patients suffering from colorectal carcinoma. J Pineal Res 1988; 5:251-8.
49. Karasek M, Dec W, Kowalski AJ, Bartsch H, Bartsch C. Serum melatonin circadian profile in women with adenocarcinoma of uterine corpus. Int J Thymol 1996; 4(suppl 1):80-3.
50. Hajak G, Rodenbeck A, Staedt J, Bandelow B, Huether G, Rüther E. Nocturnal plasma melatonin levels in patients sufferinf from chronic primary insomnia. J Pineal Res 1995; 19: 116-22.
51. Haimov I, Landon M, Zisapel N, Souroujon M, Nof D, Shlitner A, et al. Sleep disorders and melatonin rhythms in elderly people. Br Med J 1994; 309:167.
52. Tzischinsky O, Shlitner A, Lavie P. The association between the nocturnal sleep gate and nocturnal onset of urinary 6-sulphatoxymelatonin. J Biol Rhythms 1993; 8:199-209.
53. Lavie P, Haimov I, Shochat T. Melatonin-shutting off the wakefulness system. Front Horm Res 1997; 23:149-60.
54. Beck-Friis J, Kjellman BF, Wetterberg L. Serum melatonin in relation to clinical variables in patirnts with major depressive disorder and a hypothesis of a low melatonin syndrome. Acta Psych Scand 1985; 71:319-30.
55. Cavallo A, Holt KG, Meyer WJ. Melatonin circadian rhythm in childhood depression. J Am Acad Child Adolesc Psych 1987; 26:395-9.
56. Kennedy SH, Tighe S, Brown GM. Melatonin and cortisol switches during mania, depression, and euthymia in drug-free bipolar patient. J Nervous Mental Dis 1989; 177:300-3.
57. Ferrier IN, Arendt J, Johnstone EC, Crow TJ. Reduced nocturnal melatonin secretion in chronic schizophrenia. Relationship to body weight. Clin Endocrinol 1982; 17:181-7.
58. Monteleone P, Maj M, Fusco M, Kemali D, Reiter RJ. Depressed nocturnal plasma melatonin levels in drug-free paranoid schizophrenics. Schizophrynic Res 1992; 7:77-84.
59. Monteleone P, Catapano F, Maj M, Kemali D, Reiter RJ. Circadian melatonin thythm in patients with paranoid schizophrenia and obsessive-compulsive disorder. In: Touitou Y, Arendt J, Pevet P, editors. Melatonin and the pineal gland - from basic science to clinical application. Amsterdam: Excerpta Medica; 1993. p. 363-6.
60. Wetterberg L, Aperia B, Yuwiler A. Age, alcoholism and depression are associated with low levels of urinary melatonin. J Psych Neurosci 1983; 15:215-24.
61. Lewy AJ, Sack RL, Miller LS, Hoban TM. Anti-depressant and circadian phase-shifting effect of light. Science 1987; 235: 252-4.
62. Leone M, Bussone G. A review of hormonal findings in cluster headache. Evidence of hypothalamic involvement. Cephalalgia 1993; 4:213-20.
63. Monge-Strauss MF, Touitou Y, Garbarg-Chenon L, Bikacova-Rocher A, Reinberg A, Mikol F. Plasma melatonin and cortisol circadian rhythm in epileptic patients. In: Touitou Y, Arendt J, Pevet P, editors. Melatonin and the pineal gland-from basic science to clinical application. Amsterdam: Excerpta Medica; 1993. p. 371-3.
64. Ferrari E, Casale G, Dori D, Solerte SB, Fioravanti M, Magri F, et al. In: Touitou Y, Arendt J, Pevet P, editors. Melatonin and the pineal gland - from basic science to clinical application. Amsterdam: Excerpta Medica; 1993. p. 379-82.
65. Skene D, Vivien-Roels B, Sparks DL, Hansaker JC, Pevet P, Ravid D, et al. Daily variations in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: Effect of age and Alzheimer's disease. Brain Res 1990; 528:170-4.
66. Morita Y, Udrida K, Okamoto O. Melatonin rhythm of Alzheimer's patients. Melatonin: A universal photoperiodic signal with diverse action. Front Horm Res 1996; 21:180-5.
67. Reiter RJ. Oxidative damage in the central nervous system: Protection by melatonin. Progr Neurobiol 1998; 56:359-84.
68. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ. Melatonin: A potent, endogenous hydroxyradical scavenger. Endocrine J 1993; 1:57:60.
69. John TM, Liu GY, Brown GM. Electromagnetic field exposure and indoleamine metabolism: An overview. Front Horm Res 1996; 21:42-50.
70. Karasek M, Woldanska-Okonska M, Czernicki J, Zylinska K, Swietoslawski J. Chronic exposure to 2.9 mT, 40 Hz magnetic field reduces melatonin concentration in humans. J Pineal Res 1998; 25:240-4.
71. Graham C, Cook MR, Riffle DW. Human melatonin during continuous magnetic field exposure. Bioelectromagnetics 1997; 18:166-71.
72. Wurtman RJ, Lynch HJ, Sturner WQ. Melatonin in humans: Possible involvement in SIDS, and use in contraceptives. Adv Pineal Res 1991; 5:319-27.
73. Brugger P, Marktl W, Herold M. Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet 1995; 345: 1408.
74. Brismar K, Hylander B, Wetterberg L. Melatonin secretion related to side-effects of â-blockers from the central nervous system. Acta Med Scand 1988; 223:525-30.
75. Cagnacci A, Arangino S, Angiolucci M, Maschio E, Longu G, Mellis GB. Potentailly beneficial cardiovascular effects of melatonin administration in women. J Pineal Res 1997; 22:16-9.
76. Maestroni GJM, Conti A, Pierpaoli W. Pineal melatonin, its fundamental immunoregulatory role in aging and cancer. Ann NY Acad Sci 1988; 521:140-7.
77. Armstrong SM, Redman JR. Melatonin: A chronobiotic with anti-aging properties? Med Hypotheses 1991; 34:300-9.
78. Reiter RJ. The pineal gland and melatonin in relation to aging: A summary of the theories and of the data. Exp Gerontol 1995; 30:199-212.
79. Pierpaoli W, Lesnikov V. Theoretical considerations on the nature of the pineal 'ageing clock'. Gerontology 1997; 43:20-5.
80. Harman D. Free radical theory of aging. Mutat Res 1992; 275: 257-66.
81. Brown GM. 1995) Melatonin in psychiatric and sleep disorders. Therapeutic implications. CNS Drugs 1988; 3:209-26.
82. Zhdanova IV, Wurtman RJ, Schomer DI. Sleep-inducing effects of low doses of melatonin in the evening. Clin Pharmacol Ther 1995; 57:552-8.
83. Jan JE, O'Donnell ME. Use of melatonin in the treatment of paediatric sleep disorders. J Pineal Res 1996; 21:193-9.
84. Dahlitz M, Alverez B, Vignau J, English J, Arendt J, Parkers JD. Delayed sleep phase syndrome response to melatonin. Lancet 1991; 337:1121-4.
85. Stankov B, Fraschini F, Oldani A. Melatonin and delayed sleep phase syndrome: Ambulatory polygraphic evaluation. Neuro Report 1994; 6:132-4.
86. Haimov I, Lavie P, Laudon M, Herer P, Vigder C, Zisapel N. Melatonin replacement therapy of elderly insomniacs. Sleep 1995; 18:598-603.
87. Lissoni P, Barni S, Tancini G, Crispino S, Paolorossi F, Lucini V, et al. Clinical study of melatonin in untreatable advanced cancer patients. Tumori 1987; 73:475-80.
88. Karasek M, Kuzdak K, Cywinski J, Zylinska K, Smialowska A, Pluzanska A. Effects of melatonin administration in advanced breast cancer patients - preliminary report. Neuroendocrinol Lett 1998; 19:15-9.
89. Lissoni P. Neuroimmunotherapy of human neoplasms with melatonin and antitumor cytokines. Int J Thymol 1996; 4(suppl 1):84-7.
90. Lissoni P, Barni S, Meregalli S, Fossati V, Cazzaniga M, Esposti D, et al. Modulation of cancer therapy by melatonin: A phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone. Br J Cancer 1995; 71:854-6.
91. Birau N, Petersen U, Gottschalk J. Hypotensive effect of melatonin in essential hypertension. IRSC Med Sci 1981; 9:906.
92. Cohen M, Josimovich J, Brzezinski A. Melatonin: from contraception to breast cancer prevention. Maryland: Sheba Press; 1995.
93. Jean-Louis G, von Gizycki H, Zizi F. Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment. J Pineal Res 1998; 25:177-83.
94. Brusco LI, Márquez M, Cardinali DP. Monozygotic twins with Alzheimer's disease treated with melatonin: Case report. J Pineal Res 1998; 25:260-3.
95. Brusco LI, Márquez M, Cardinali DP. Melatonin treatment stabilizes chronobiologic and cognitive symptoms in Alzheimer's disease. Neuroendocrinol Lett 1998; 19:111-5.
96. Rogers NL, Phan O, Kannaway DJ, Dawson D. Effect of day-time oral melatonin administration on neurobehavioral performance in humans. J Pineal Res 1998; 25:47-53.